SkinSync is a patented dermal patch technology based on dissolving nanofibrous mats. This unique dissolution behaviour leads to the release of more than 95% of the active ingredient, in stark contrast with traditional patches where 50-95% of the active payload remains in the patch after use and gets discarded.

Our patches are also highly efficient, needing up to 30× less active to deliver the needed concentration of the active, to and through the skin. This further translates into highly economical and, potentially smaller, more patient-friendly patches.